Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion.
Nature communications
View this publicationNature communications
View this publicationAlzheimer's research & therapy
View this publicationThe British journal of dermatology
View this publicationFrontiers in immunology
View this publicationJournal of clinical medicine
View this publicationCirculation
View this publicationOsteoarthritis and cartilage
View this publicationJournal of imaging
View this publicationBMC cancer
View this publicationPloS one
View this publication